PPD expands bioanalytical laboratory capabilities

Skip to Navigation


  • Published: Sep 20, 2019
  • Source: PPD
  • Channels: Proteomics & Genomics / Gas Chromatography / Sample Preparation / Laboratory Informatics / Ion Chromatography / Detectors / HPLC / MRI Spectroscopy / NMR Knowledge Base / Atomic / UV/Vis Spectroscopy / X-ray Spectrometry / Infrared Spectroscopy / Base Peak / Raman / Chemometrics & Informatics / Proteomics

Pharmaceutical Product Development (PPD), a global contract research organization, is expanding its bioanalytical laboratory in Richmond, Virginia, US, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs.

The expansion of the lab’s immunochemistry, biomarker and chromatography services builds on PPD’s ongoing investments in its Richmond facilities, which have also included significant previous enhancements to its vaccine sciences, biomarker, genomics and automation services. The current expansion includes growing the lab’s immunochemistry and biomarker space by 8000 square feet, which will be used for both biomarker lab capacity and a dedicated lab team for one of PPD’s global biopharmaceutical clients.

The company anticipates adding some 200 new positions as a result of its continuing expansion at the bioanalytical lab. PPD Laboratories’ operation in Richmond, elements of which have been in operation since 1985, currently totals more than 250,000 square feet, making it one of the largest bioanalytical labs in the world. Today, the lab employs more than 1000 people, including PhD-level scientists, analytical laboratory staff and other scientific professionals.

Additionally, the company plans to begin the process of adding 30,000 square feet of space dedicated to chromatography services. This step will enable PPD to design and build a state-of-the-art facility focusing on modern mass spectrometry and automation, and offering a layout optimized for the bioanalysis of complex molecules, such as antibody-drug conjugates, and advanced biotherapeutics, such as cell and gene therapies. Work is also scheduled to begin this month to create a 4,500-square-foot cell lab. This summer, PPD completed the move of administrative staff into 36,000 square feet at One Holland Place. And, earlier this year the company completed an 8,600-square-foot expansion to its sample management and biorepository offerings.

“The ongoing expansion of our bioanalytical lab – coupled with previous enhancements to our biologics capabilities – builds on the growth of our drug development expertise over the past three decades to the point that we now support pharmaceutical programs from preclinical through post-approval,” said Christopher Fikry, executive vice president of PPD Laboratories. “These additions – which we are thankful Virginia and Henrico County officials have welcomed and supported – will enable us to more effectively and efficiently respond to the growing needs of our customers as they seek to deliver more life-changing therapies. We’re confident these enhancements will enable us to continue our record of success with our customers.”

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in spectroscopy? Visit our sister site spectroscopyNOW.com

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved